✦ LIBER ✦

Combined therapy in breast cancer

✍ Scribed by V. Shanta; S. Krishnamurthi

Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 290 KB
Volume: 4
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930040104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of combined hormone therapy in a

Results of combined hormone therapy in advanced breast cancer

✍ Edward F. Lewison; Frances H. Trimble; John L. Grow; Teruo Masukawa 📂 Article 📅 1963 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 2 views

Combined estrogenic and androgenic hormo

Combined estrogenic and androgenic hormone therapy in advanced breast cancer

✍ B. J. Kennedy; John H. Brown 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 2 views

Combination therapy of hormone and cytot

Combination therapy of hormone and cytotoxic agents in advanced breast cancer

✍ David T. Kiang; Daniel H. Frenning; Juliette Gay; Anne I. Goldman; B. J. Kennedy 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

The effectiveness of combination therapy with diethylstilbestrol, cyclophosphamide, and 5-fluorouracil (DES + CTx + FU) was compared with DES alone or CTx + FU in 87 postmenopausal women with advanced breast cancer. Therapy was randomized according to the tumor estrogen-receptor (ER) status. In 30

Combined endocrine effects of LHRH agoni

Combined endocrine effects of LHRH agonist (Zoladex®) and tamoxifen (Nolvadex®) therapy in premenopausal women with breast cancer

✍ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oöphorectomy or in postmenopausal women. The standard first line hormonal treatment

Disseminated breast cancer: Evaluation o

Disseminated breast cancer: Evaluation of hormonal therapy utilizing stilbestrol and medrogestone (AY-62022) singly and in combination

✍ David L. Ahmann; Richard G. Hahn; Harry F. Bisel 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

Pharmacokinetic, biochemical and clinica

Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide–bischloroethylnitrosourea combination therapy in patients with advanced breast cancer

✍ Mark Clemons; Malcolm Ranson; Jennifer M. Margison; Hassan El Teraifi; Audrey Gr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB

## Abstract We assessed whether split dosing with the methylating agent DTIC is an effective strategy for inactivating the DNA repair protein __O__6‐alkylguanine DNA‐ATase in order to decrease tumour resistance to BCNU. ATase levels in PBMCs were used as a surrogate for tumour ATase depletion to de